This has included studies in various breast cancer subtypes wherein breast cancers are characterized by the presence of receptors such as estrogen receptor (ER), progesterone receptor (PR), and HER2/ErbB2 receptor (HER2) or by the absence of all of them, the triple negative breast cancers (TNBCs). Here, ESR1 is linked to triple-negative breast carcinoma.